NCT04085445 - "An All-Comers Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients" | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

August 31, 2022

Study Completion Date

September 3, 2024

Conditions

Chinese Patients Treated With Agent DCB

Interventions

DEVICE

AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter

To compile the real-world clinical outcome data for the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter (Agent DCB) used in percutaneous coronary intervention (PCI) in Chinese patients.

Trial Locations (9)

970

Hualien Tzu Chi Hospital, Hualien City

Unknown

Queen Mary Hospital, Hong Kong

Tan Tock Seng Hospital, Singapore

Kaohsiung Veterans General Hospital, Kaohsiung City

China Medical University Hospital, Taichung

Cheng Hsin General Hospital, Taipei

Mackay Memorial Hospital, Taipei

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei